Treatment of high-risk patients with coronavirus disease 2019 and convalescent immunoglobulin G compared with convalescent plasma failed to reach noninferiority on day 14 but was superior on day 28. In particular, survival and clinical improvement was better in unvaccinated patients treated with immunoglobulin G.
All Keywords
【저자키워드】 COVID-19, immunoglobulins, plasma,
【저자키워드】 COVID-19, immunoglobulins, plasma,